Yahoo India Web Search

Sign In

Search results

    • Image courtesy of empr.com

      empr.com

      • Ofev® is part of a group of medicines known as 'anti-fibrotics' and contains the active ingredient nintedanib. It is used in the treatment of Idiopathic Pulmonary Fibrosis or other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype.
      public.boehringer-ingelheim.com/uk/products/ofev-nintedanib-esilate-progressive-pulmonary-fibrosis

      Ofev® (nintedanib esilate) - Boehringer Ingelheim

  2. People also ask

  3. pro.boehringer-ingelheim.com › us › productsTreatment Option for Adults With IPF & SSc-ILD | OFEV ...

    Efficacy data. SSc-ILD. The first antifibrotic therapy FDA approved to slow the rate of decline of pulmonary function in patients with SSc-ILD 1,3. Efficacy data. Updated 2022 ATS/ERS/JRS/ALAT Clinical Practice Guideline. Review the treatment recommendations for OFEV® (nintedanib) Nintedanib 3D MOA.

    • SSc-ILD

      In the SSc-ILD study, bleeding events were reported in 11%...

    • Lung Function

      Lung Function - Treatment Option for Adults With IPF &...

    • Safety Data

      Safety Data - Treatment Option for Adults With IPF & SSc-ILD...

    • Secondary Endpoints

      Secondary Endpoints - Treatment Option for Adults With IPF &...

  4. www.ofev.com › what-is-ofevFacts About OFEV® (nintedanib) capsules

    Pill not shown. at actual size. FACT 1: OFEV Works to Preserve More Lung Function. OFEV was first approved in 2014 to treat adults with IPF, one of the most common ILDs. In 2019, it became the first FDA-approved therapy to slow the rate of decline in lung function in adults with SSc-ILD.

  5. www.actionpf.org › information-support › anti-fibroNintedanib and Pirfenidone - antifibrotics for pulmonary ...

    • What Are Antifibrotics?
    • Nintedanib
    • Pirfenidone
    • Privately Purchasing Antifibrotic Medication
    • Other Medications

    Antifibrotic medications like nintedanib and pirfenidone can slow down the build-up of scar tissue or fibrosis in the lungs and can be used to treat pulmonary fibrosis. These treatments may reduce the rate that your lung fibrosis progresses but they don’t stop the lung scarring completely or get rid of any scar tissue that has already formed. You c...

    See full list on actionpf.org

    Nintedanib is an antifibrotic medication used to treat pulmonary fibrosis. Your medical team will prescribe you nintedanib for as long as it’s helping you, unless you have significant side effects. 1. Take nintedanib twice a day, ideally 12 hours apart, with or straight after food. Don’t chew or crush the capsule, but swallow it whole. 2. Most peop...

    See full list on actionpf.org

    Pirfenidone is an antifibrotic pulmonary fibrosis treatment. Your medical team will prescribe you pirfenidone for as long as it’s helping you, unless you have significant side effects. 1. Take pirfenidone three times a day, with or straight after food. Swallow the tablet whole and don’t chew or crush it. 2. The full dose of pirfenidone is 801mg thr...

    See full list on actionpf.org

    Some people face long waiting times to be diagnosed and prescribed antifibrotics by a specialist ILD team. This can be an anxious time, and some people consider purchasing antifibrotic treatments privately, before a formal diagnosis and treatment plan are agreed upon with an ILD team. At APF, we do not recommend the private purchase of antifibrotic...

    See full list on actionpf.org

    You may also be offered other treatment – such as medications to help manage a cough or breathlessness, and over-the-counter medicines and advice to manage acid reflux.

    See full list on actionpf.org

  6. www.fda.gov › news-events › press-announcementsFDA Approves First Treatment for Group of Progressive ...

    The U.S. Food and Drug Administration today approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a...

  7. pro.boehringer-ingelheim.com › sg › inflammationOFEV® is the first and only approved therapy for PF-ILD

    OFEV® stands as the pioneering and First approved treatment for progressive fibrosing interstitial lung disease (PF-ILD).

  8. www.boehringer-ingelheim.com › human-healthOfev® Indicated for Idiopathic Pulmonary Fibrosis (IPF ...

    Ofev®. Ofev is used to treat idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD) and other lung diseases, learn more here.

  9. www.ofev.com › understanding-ildChronic ILD with Worsening Fibrosis | OFEV® (nintedanib) capsules

    Chronic ILDs with Worsening Fibrosis. Scleroderma-associated ILD. IPF is one of the most common forms of ILD with fibrosis. It is a serious and progressive disease, meaning it gets worse over time. It causes permanent scarring of the lungs, which results in impaired lung function.